on Gastrointestinal Imaging
暂无分享,去创建一个
K. | A. Zaheer | I. Kamel | L. Carucci | M. Bashir | K. Thakrar | L. Solnes | Abhinav Vij | R. Wardrop | Alice W Fung | S. Wahab | Lilja | D. E. Kaplan | G. Russo | Kristin | Porter | B. McGuire | MD Laura R. Carucci | M. P. Kristin K. Porter | Elainea N. Smith | MD o Atif Zaheer | M. P. V. Ihab R. Kamel | MD a Mustafa R. Bashir | MD a Hina Arif-Tiwari | MD e Alice Fung | MD MSc David E. Kaplan | MD g Brendan M. McGuire | MD h Gregory K. Russo | MD Elainea N. Smith | M. M. J. Bjork Solnes | MD k Kiran H. Thakrar | MD Mph Abhinav Vij | MD m Shaun A. Wahab | M. P. N. Richard M. Wardrop III
[1] Wen Cheng,et al. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI , 2020, BMC Medical Imaging.
[2] A. Ba-Ssalamah,et al. Quantification of liver function using gadoxetic acid-enhanced MRI , 2020, Abdominal Radiology.
[3] T. Cotter,et al. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease , 2020 .
[4] L. Henry,et al. Epidemiology of Non-alcoholic Fatty Liver Disease in North America. , 2020, Current pharmaceutical design.
[5] Anthony C Breu,et al. A Multicenter Study Into Causes of Severe Acute Liver Injury , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] E. Jung,et al. Proof of principle: Estimation of liver function using color coded Doppler sonography of the portal vein. , 2019, Clinical hemorheology and microcirculation.
[7] Manish Dhyani,et al. Current status of imaging in nonalcoholic fatty liver disease , 2018, World journal of hepatology.
[8] Seamus O'Reilly,et al. Use of Liver Imaging and Biopsy in Clinical Practice. , 2017, The New England journal of medicine.
[9] Mark Hudson,et al. Guidelines on the management of abnormal liver blood tests , 2017, Gut.
[10] A. Teufel,et al. Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry , 2017, Scientific Reports.
[11] C. Lisanti,et al. Mild asymptomatic intrahepatic biliary dilation after cholecystectomy, a common incidental variant , 2017, Abdominal Radiology.
[12] F. Wacker,et al. Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC) , 2016, European Radiology.
[13] P. Cotton,et al. An assessment of existing risk stratification guidelines for the evaluation of patients with suspected choledocholithiasis , 2016, Surgical Endoscopy.
[14] E. Tapper,et al. The Incidence and Outcomes of Ischemic Hepatitis: A Systematic Review with Meta-analysis. , 2015, The American journal of medicine.
[15] M. Koplay,et al. Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. , 2015, World journal of hepatology.
[16] Mohammad Hassan Murad,et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[17] Y. Takwoingi,et al. Ultrasound versus liver function tests for diagnosis of common bile duct stones. , 2015, The Cochrane database of systematic reviews.
[18] M. Heller,et al. The role of ultrasonography in the evaluation of diffuse liver disease. , 2014, Radiologic clinics of North America.
[19] Hanry Yu,et al. Correlation of MR elastography with morphometric quantification of liver fibrosis (Fibro‐C‐Index) in chronic hepatitis B , 2014, Magnetic resonance in medicine.
[20] S. Wells. Quantification of hepatic fat and iron with magnetic resonance imaging. , 2014, Magnetic resonance imaging clinics of North America.
[21] L. Marzio,et al. CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. , 2014, World journal of hepatology.
[22] R. Fimmers,et al. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests , 2014, European Radiology.
[23] A. Schreyer,et al. MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score , 2014, Scientific Reports.
[24] Li Ying,et al. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta‐analysis of diagnostic accuracy , 2014, Journal of gastroenterology and hepatology.
[25] Diego R. Martín,et al. MRI of diffuse liver disease: characteristics of acute and chronic diseases. , 2014, Diagnostic and interventional radiology.
[26] D. Gwon,et al. Living donor liver transplantation: the Asian perspective. , 2014, Transplantation.
[27] M. Khoshbaten,et al. Hepatic Artery and Portal Vein Doppler Indexes in Non-alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs , 2014, International journal of preventive medicine.
[28] M. Metcalfe,et al. Serology and ultrasound for diagnosis of choledocholithiasis. , 2014, Annals of the Royal College of Surgeons of England.
[29] Divya Singh,et al. Imaging of non alcoholic fatty liver disease: A road less travelled , 2013, Indian journal of endocrinology and metabolism.
[30] Owaid M. Almalki,et al. Non-invasive assessment of choledocholithiasis in patients with gallstones and abnormal liver function. , 2013, World journal of gastroenterology.
[31] R. Nakhleh,et al. Non‐invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C , 2013, Clinical transplantation.
[32] J. Yee,et al. ACR appropriateness criteria jaundice. , 2013, Journal of the American College of Radiology : JACR.
[33] R. Idilman,et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. , 2013, Radiology.
[34] Chang Duck Kim,et al. Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis. , 2013, World journal of gastroenterology.
[35] M. C. Chammas,et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. , 2013, Ultrasound in medicine & biology.
[36] Maria Krystyna Walas,et al. Standards of the Polish Ultrasound Society – update. The liver, gallbladder and bile ducts examinations , 2012, Journal of ultrasonography.
[37] G. Israel,et al. Detection of hepatic steatosis on contrast-enhanced CT images: diagnostic accuracy of identification of areas of presumed focal fatty sparing. , 2012, AJR. American journal of roentgenology.
[38] H. Völzke,et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. , 2012, Radiology.
[39] D. Nanz,et al. MRI: the new reference standard in quantifying hepatic steatosis? , 2011, Gut.
[40] S. Reeder,et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy , 2011, Journal of magnetic resonance imaging : JMRI.
[41] Eliseo Guallar,et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis , 2011, Hepatology.
[42] J. Veniero,et al. Gd-EOB-DTPA as a Functional MR Cholangiography Contrast Agent: Imaging Gallbladder Filling in Patients With and Without Hepatobiliary Dysfunction , 2011, Journal of computer assisted tomography.
[43] R. Ehman,et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. , 2011, Radiology.
[44] J. Schofer. Biliary causes of postcholecystectomy syndrome. , 2010, The Journal of emergency medicine.
[45] Ernesto Roldan-Valadez,et al. In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry. , 2010, Journal of hepatology.
[46] I. Song,et al. Acute hepatitis A: correlation of CT findings with clinical phase. , 2010, Hepato-gastroenterology.
[47] Thomas M van Gulik,et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. , 2010, Radiology.
[48] T. Tongdee,et al. Accuracy of multidetector computed tomography cholangiography in evaluation of cause of biliary tract obstruction. , 2010, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[49] Seong Ho Park,et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. , 2010, Journal of hepatology.
[50] Marco Salvatore,et al. Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. , 2009, Metabolism: clinical and experimental.
[51] Zamir Halpern,et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. , 2009, AJR. American journal of roentgenology.
[52] Diego R. Martín,et al. Gadolinium-Enhanced Imaging of Liver Tumors and Manifestations of Hepatitis: Pharmacodynamic and Technical Considerations , 2009, Topics in magnetic resonance imaging : TMRI.
[53] B. Neuschwander‐Tetri,et al. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. , 2008, Archives of internal medicine.
[54] U. Malmqvist,et al. Muscular exercise can cause highly pathological liver function tests in healthy men. , 2008, British journal of clinical pharmacology.
[55] S. Curley,et al. Comparison of CT methods for determining the fat content of the liver. , 2007, AJR. American journal of roentgenology.
[56] Sang Won Lee,et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.
[57] J. Sarrazin,et al. The halo sign and peripancreatic fluid: useful CT signs of hypovolaemic shock complex in adults. , 2005, Clinical radiology.
[58] Diego R. Martín,et al. Reversible heterogeneous arterial phase liver perfusion associated with transient acute hepatitis: Findings on gadolinium‐enhanced MRI , 2004, Journal of magnetic resonance imaging : JMRI.
[59] P. Ros,et al. The infected liver: radiologic-pathologic correlation. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.
[60] Frcpc,et al. Abnormal Liver Function Tests , 2003 .
[61] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[62] R. Schreiber,et al. Jaundice in older children and adolescents. , 2001, Pediatrics in review.
[63] K Sackey,et al. Hemolytic anemia: Part 1. , 1999, Pediatrics in review.
[64] C. Dietrich,et al. Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. , 1998, AJR. American journal of roentgenology.
[65] E. Fishman,et al. Nonneoplastic liver disease: evaluation with CT and MR imaging. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.
[66] R. E. Hendrick,et al. Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements , 1998, Abdominal Imaging.
[67] L Dalla Palma,et al. Noninvasive in vivo quantitative assessment of fat content in human liver. , 1997, Journal of hepatology.
[68] K. Lindor,et al. Diagnosis and therapy of cholestatic liver disease. , 1996, The Medical clinics of North America.
[69] G. Dodd,et al. Hepatic infarction caused by arterial insufficiency: spectrum and evolution of CT findings. , 1996, AJR. American journal of roentgenology.
[70] O. Matsui,et al. Intrahepatic periportal abnormal intensity on MR images: an indication of various hepatobiliary diseases. , 1989, Radiology.
[71] R. Lerner,et al. Contracted gallbladder: a finding in hepatic dysfunction. , 1985, Radiology.
[72] P. Ralls,et al. Thickening of the gallbladder wall in acute hepatitis: ultrasound demonstration. , 1982, Radiology.
[73] B. Goldberg,et al. Ultrasound findings in hepatitis. , 1980, Radiology.
[74] Harmeet Kaur,et al. ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma. , 2017, Journal of the American College of Radiology : JACR.
[75] I. Kamel,et al. ACR Appropriateness Criteria® Chronic Liver Disease. , 2017, Journal of the American College of Radiology : JACR.
[76] J. Saltzman. Continuing Medical Education: January 2017: ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries , 2017, The American Journal of Gastroenterology.
[77] Y. Yamashita,et al. Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement? , 2011, Japanese Journal of Radiology.
[78] S. Kargar,et al. Role of liver function enzymes in diagnosis of choledocholithiasis in biliary colic patients. , 2011, Acta medica Iranica.
[79] James S Babb,et al. Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. , 2007, Radiology.
[80] Shin Aoyama,et al. The Asian Perspective , 2005 .
[81] T. Murakami,et al. Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings. , 1996, Radiology.
[82] M. Black,et al. Drug induced liver disease. , 1983, Postgraduate medical journal.
[83] Neha Garg,et al. Living donor liver , 2022 .